JOIN OUR EMAIL LIST!
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • Programs
      • Golf
      • Emerging Leaders
      • Membership
      • Vendor Night
      • Social Media & Networking
      • Student Affairs
      • Women in Pharma®
      • Webmaster Committee
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
  • RESOURCES
    • ISPE Publications
    • ISPE Training
  • Blog
    • ISPE Blog
  • Gallery
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • Programs
      • Golf
      • Emerging Leaders
      • Membership
      • Vendor Night
      • Social Media & Networking
      • Student Affairs
      • Women in Pharma®
      • Webmaster Committee
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
  • RESOURCES
    • ISPE Publications
    • ISPE Training
  • Blog
    • ISPE Blog
  • Gallery

ISPE LA 30th Annual Vendor Night Innovation Showcase Exhibit Show

  • Posted by ISPE Greater Los Angeles
  • On January 17, 2024
Calendar
Tickets
Add to Calendar
  • Add to Timely Calendar
  • Add to Google
  • Add to Outlook
  • Add to Apple Calendar
  • Add to other calendar
  • Export to XML
When:
May 23, 2024 @ 2:00 pm – 8:00 pm America/Los Angeles Timezone
2024-05-23T14:00:00-07:00
2024-05-23T20:00:00-07:00
Where:
The Queen Mary
1126 Queens Hwy
Long Beach, CA 90802
USA
Contact:
Kimberly Syre
(949) 285-3848
Social Events

Download Event Flyer: ISPE LA 2024 Vendor Night Flyer

Attendee Registration: https://forms.gle/GMr8nAuKZR4K7tZp8

Exhibit Table Registration: https://atdevents.net/event.php?id=604

 

Keynote:

Impact of AI in the Life Science Industry

Dr. Rodney Sappington

2:00PM – 2:30PM

Using AI & ML in the Development of Drug & Biological Products

Abstract:

The FDA recognizes the growing role of Artificial Intelligence and Machine Learning in the drug development lifecycle and across a diverse range of therapeutic areas.  These technologies are increasingly used across various stages of drug development, from discovery to postmarket safety surveillance.  This talk will cover the landscape of potential and current uses of AI/ML, considerations for the use of AI/ML, and next steps and engagement with industry.

Dr. Rodney Sappington’s groundbreaking research has significantly impacted the landscape of artificial intelligence (AI) and machine learning, particularly in the realms of medical diagnostics, drug discovery, and nanomaterial manufacturing. With over two decades of experience in these fields, he has pioneered innovative methodolgies that have revolutionized early disease detection and therapeutic development. His work has extended in multi-agent-based research in AI Alignment for on capturing the emergence of prosocial and antisocial algorithmic behavior.

 

One of Dr. Sappington’s notable achievements lies in his adept utilization of deep learning techniques for the early identification of high-mortality diseases. His pioneering approach has not only transformed critical healthcare practices but has also set new standards for the integration of AI in medical applications. By pushing the boundaries of technology, Dr. Sappington has demonstrated a steadfast commitment to tackling pressing healthcare challenges head-on.

 

Beyond healthcare, Dr. Sappington’s influence extends into the realms of AI and machine learning systems and software development at scale. His visionary leadership has propelled the creation of advanced manufacturing platforms tailored for nanomaterial optimization. These platforms have played a pivotal role in addressing diverse challenges, from ensuring clean water access to facilitating advancements in zero-gravity environments. He is currently focused in muti-agent based deep reinforcement learning for creating artificial empathy in early AGI to prevent sociopathic AI.

 

Throughout his career, Dr. Sappington has demonstrated a multifaceted approach to problem-solving, blending technical expertise with a keen understanding of human-centered design principles. His interdisciplinary background has equipped him with a unique perspective, enabling him to navigate complex challenges with agility and foresight. Dr. Sappington’s advocacy for a human-centered approach to AI underscores his unwavering dedication to prioritizing societal benefits and mitigating potential adverse impacts on human lives.

 

BioPhy

Scott Kobayashi

2:30PM – 3:00PM

Exploring the Impact of AI: Improving Efficiency in Life Sciences Manufacturing

Abstract:

Artificial Intelligence technologies like Machine Learning,  GenAI and predictive analytics can optimize processes in Life Science manufacturing.  We will discuss leveraging AI for real-time monitoring and process control, predictive maintenance and asset optimization, and GenAI Copilot for increasing engineering productivity.

Scott Kobayashi is currently the Sr. VP of Sales at BioPhy, an AI Drug Development company with industry-leading Predictive and Generative AI solutions for the Life Sciences industry.  Scott has twenty years of biopharma experience and was previously Sr. VP of Client Delivery at Verista, and prior to that, co-founder and CEO of Delta Project Management, a CQV and Capital Project Management consulting firm.

 

Rockwell Automation

Niraj Kachhadia

3:00PM – 3:30PM

Niraj Kachhadia has over 15 years of industry expertise in designing and delivering automation and manufacturing IT solutions in life sciences, material handling, Oil & Gas, and chemical industries.

He has MS in Electrical Engineering from University of Texas at Arlington with focus in Automation & Robotics, and bachelor’s degree in Instrumentation & Control systems from Nirma Institute of Technology, India.

Prior to Rockwell Automation, Niraj held leadership positions at Siemens and Kim Automation Inc.

 

Panel Discussion:

Rodney Sappington | Scott Kobayashi | Niraj Kachhadia | David Jaenisch

3:30PM – 4:00PM

 

 

Executive Night

ISPE Summer Golf Tournament

Scroll
Follow Us
Search this Site
©2023 ISPE Greater Los Angeles Chapter. All rights reserved.